Faculty profile

Ashleigh Tuite

Back to faculty

Assistant ProfessorEpidemiology DivisionUniversity of Toronto

Ashleigh Tuite

Assistant Professor

Epidemiology Division

Dalla Lana School of Public Health

University of Toronto

Toronto, Ontario, Canada

Scholar ORCID

Supervision signals

Professors usually supervise graduate students in their department's programs.
13 publications in the last five years, latest in 2025.
Senior (last) author on 1 recent paper, a sign of leading a research group.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Education

PhD, Epidemiology and Mathematical Modeling
MPH, Epidemiology
MSc, Biochemistry
HBSc, Biochemistry

Profiles and links

University Profile Google Scholar iDORCID

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Initial Effectiveness of mRNA-1273 Against SARS-CoV-2 Infection and Hospitalization in Young Children.
Open forum infectious diseases · 2025
Switching from a 2-dose to a 1-dose program of gender-neutral routine vaccination against human papillomavirus in Canada: a mathematical modelling analysis.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2024
Mathematical modelling for pandemic preparedness in Canada: Learning from COVID-19
Canada Communicable Disease Report · 2024

All 27 publications

Latest funding

Canada Unvaccinated: Modeling Resurgence Risk of Vaccine-Preventable Diseases in Canada
CIHR · 2025 · Co-investigator
$524,026
Potential impact and cost-effectiveness of emerging RSV immunization strategies: Advancing analytical methods for integrating spatio-demographic and equity considerations into evaluations
CIHR · 2024 · Co-investigator
$409,276
Optimizing HPV vaccination programs in Low- and Middle-Income Countries (LMIC) and Canada to reduce inequalities and reach global elimination of cervical cancer: An integrated knowledge translation dynamic-modeling approach
CIHR · 2024 · Co-investigator
$902,701

All 12 grants and awards

27 publications.

Initial Effectiveness of mRNA-1273 Against SARS-CoV-2 Infection and Hospitalization in Young Children.

Aglipay M, Maguire JL, Swayze S, Tuite A, Mamdani M, Keown-Stoneman C, Birken CS, Kwong JC

Open forum infectious diseases2025

DOI: 10.1093/ofid/ofae718 PMID: 39758749

Switching from a 2-dose to a 1-dose program of gender-neutral routine vaccination against human papillomavirus in Canada: a mathematical modelling analysis.

Drolet M, Laprise JF, Chamberland É, Sauvageau C, Wilson S, Lim GH, Ogilvie G, Tuite A, Brisson M

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2024

DOI: 10.1503/cmaj.240787 PMID: 39374971

Mathematical modelling for pandemic preparedness in Canada: Learning from COVID-19

Ogden NH, Acheson ES, Brown K, Champredon D, Colijn C, Diener A, Dushoff J, Earn DJ, Gabriele-Rivet V, Gangbè M

Canada Communicable Disease Report202413 citations

DOI: 10.14745/ccdr.v50i10a03

Seroprevalence of SARS-CoV-2 antibodies among children receiving primary care in Toronto, Ontario

Aglipay M, Kwong JC, Colwill K, Gringas A-C, Tuite A, Mamdani M, Keown-Stoneman C, Birken C, Maguire J

Canadian Journal of Public Health20243 citations

DOI: 10.17269/s41997-024-00916-3

Using spatial and population mobility models to inform outbreak response approaches in the Ebola affected area, Democratic Republic of the Congo, 2018-2020.

Huber C, Watts A, Thomas-Bachli A, McIntyre E, Tuite A, Khan K, Cetron M, Merrill RD

Spatial and spatio-temporal epidemiology2023

DOI: 10.1016/j.sste.2022.100558 PMID: 36707191

Generating simple classification rules to predict local surges in COVID-19 hospitalizations.

Yaesoubi R, You S, Xi Q, Menzies NA, Tuite A, Grad YH, Salomon JA

Health care management science2023

DOI: 10.1007/s10729-023-09629-4 PMID: 36692583

A proportional incidence rate model for aggregated data to study the vaccine effectiveness against COVID-19 hospital and ICU admissions.

Yan P, Mullah MAS, Tuite A

Biometrics2023Senior author

DOI: 10.1111/biom.13915 PMID: 37561066

Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021.

Lin YJ, Evans DH, Robbins NF, Orjuela G, Abe KT, Rathod B, Colwill K, Gingras AC, Tuite A, Yi QL, O'Brien SF, Drews SJ

Microbiology spectrum2023

DOI: 10.1128/spectrum.05256-22 PMID: 37289096

Relative pandemic severity in Canada and four peer nations during the SARS-CoV-2 pandemic.

Peng A, Simmons A, Amoako A, Tuite A, Fisman D

Canada communicable disease report = Releve des maladies transmissibles au Canada2023

DOI: 10.14745/ccdr.v49i05a05 PMID: 38419909

Governing partnerships with technology companies as part of the COVID-19 response in Canada: A qualitative case study.

Harish V, Samson TG, Diemert L, Tuite A, Mamdani M, Khan K, McGahan A, Shaw JA, Das S, Rosella LC

PLOS digital health2022

DOI: 10.1371/journal.pdig.0000164 PMID: 36812643

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Ashleigh Tuite

Research

Latest papers

Latest funding

Initial Effectiveness of mRNA-1273 Against SARS-CoV-2 Infection and Hospitalization in Young Children.

Switching from a 2-dose to a 1-dose program of gender-neutral routine vaccination against human papillomavirus in Canada: a mathematical modelling analysis.

Mathematical modelling for pandemic preparedness in Canada: Learning from COVID-19

Seroprevalence of SARS-CoV-2 antibodies among children receiving primary care in Toronto, Ontario

Using spatial and population mobility models to inform outbreak response approaches in the Ebola affected area, Democratic Republic of the Congo, 2018-2020.

Generating simple classification rules to predict local surges in COVID-19 hospitalizations.

A proportional incidence rate model for aggregated data to study the vaccine effectiveness against COVID-19 hospital and ICU admissions.

Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021.

Relative pandemic severity in Canada and four peer nations during the SARS-CoV-2 pandemic.

Governing partnerships with technology companies as part of the COVID-19 response in Canada: A qualitative case study.

CANMOD: Canadian Network for Modelling Infectious Disease

Frequent collaborators

David Fisman

Anne-Claude Gingras

Kamran Khan

Muhammad Mamdani

Jonathan Dushoff

Amy Greer

Mary Aglipay

David Champredon

Liane Macdonald

Gina Ogilvie

Catherine Birken

Marc Brisson

Sunit Das

Aisha Lofters

Michael Wolfson

Aisha Lofters

Leonid Chindelevitch

Caroline Colijn

Sarah Wilson

Eric Duku

Rahim Moineddin